SCHEMBL24129458

SCHEMBL24129458

COCCn1c(SC)nc2ccccc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.61
TSHR P16473 6/20 0.60
RAB9A P51151 5/20 0.60
LMNA P02545 3/20 0.60
NPC1 O15118 3/20 0.60
AR P10275 2/20 0.60
SMN1; SMN2 Q16637 3/20 0.56
MAPT P10636 3/20 0.56
HTT P42858 3/20 0.56
MAPK1 P28482 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
KDM4E B2RXH2 3/20 0.56
ALDH1A1 P00352 2/20 0.56
GLA P06280 1/20 0.56
GAA P10253 1/20 0.56
POLB P06746 1/20 0.55
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
CASR P41180 1/20 0.53
TP53 P04637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5009001 0.80 HPGD (0.70) HPGDTSHRRAB9ALMNANPC1
SCHEMBL11707322 0.79 HTT (0.58) HPGDTSHRLMNASMN1; SMN2MAPT
SCHEMBL11201897 0.79 HTT (0.55) HPGDTSHRLMNASMN1; SMN2MAPT
SCHEMBL569213 0.78 NPSR1 (0.59) TSHRRAB9ALMNANPC1AR
SCHEMBL18046824 0.78 HPGD (0.64) HPGDTSHRRAB9ALMNANPC1
SCHEMBL18584288 0.78 HPGD (0.64) HPGDTSHRRAB9ALMNANPC1
SCHEMBL3144343 0.78 HPGD (0.64) HPGDTSHRRAB9ALMNANPC1
SCHEMBL15595665 0.78 POLB (0.69) HPGDTSHRRAB9ANPC1SMN1; SMN2
SCHEMBL5717617 0.78 HTT (0.53) HPGDTSHRRAB9ALMNASMN1; SMN2
SCHEMBL4944465 0.78 MAPT (0.53) HPGDTSHRLMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021257828-A1 SUBSTITUTED THIENOPYRIMIDINES THAT INTERACT WITH THE RAS SUPERFAMILY FOR THE TREATMENT OF CANCERS, INFLAMMATORY DISEASES, RASOPATHIES, AND FIBROTIC DISEASE SHY THERAPEUTICS, LLC (US) 2021-12-23 WO disclosed